The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab

  1. Forero-Castro, M.
  2. Robledo, C.
  3. Lumbreras, E.
  4. Benito, R.
  5. Hernández-Sánchez, J.M.
  6. Hernández-Sánchez, M.
  7. García, J.L.
  8. Corchete-Sánchez, L.A.
  9. Tormo, M.
  10. Barba, P.
  11. Menárguez, J.
  12. Ribera, J.
  13. Grande, C.
  14. Escoda, L.
  15. Olivier, C.
  16. Carrillo, E.
  17. García de Coca, A.
  18. Ribera, J.-M.
  19. Hernández-Rivas, J.M.
Journal:
British journal of haematology

ISSN: 1365-2141

Year of publication: 2016

Volume: 172

Issue: 3

Pages: 428-438

Type: Article

DOI: 10.1111/BJH.13849 GOOGLE SCHOLAR

Sustainable development goals